Tenaya Therapeutics (TNYA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Tenaya Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $6.0M of TNYA stock on the open market.
Get emailed when insiders cluster-buy stocks like TNYA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TNYA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $21K | 8 |
| Q2 2026 | — | 0 | $6K | 3 |
| Q1 2026 | — | 0 | $5.9M | 21 |
| Q4 2025 | — | 0 | $10K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Tenaya Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $6.0M. 0 of 35 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 17SEC | Faraz AliCEO | Sell | 7,406417,782 held (−2%) | $0.71 | $5K | -18.3% | — |
| Aug 17SEC | Faraz AliCEO | Sell | 5,837434,177 held (−1%) | $0.71 | $4K | -18.3% | — |
| Aug 17SEC | Faraz AliCEO | Sell | 5,020425,188 held (−1%) | $0.71 | $4K | -18.3% | — |
| Aug 17SEC | Faraz AliCEO | Sell | 3,969430,208 held (−1%) | $0.71 | $3K | -18.3% | — |
| Aug 17SEC | Whittemore TingleyChief Medical Officer | Sell | 2,279214,073 held (−1%) | $0.71 | $2K | -18.3% | — |
| Aug 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,871216,352 held (−1%) | $0.71 | $1K | -18.3% | — |
| Aug 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,637219,860 held (−1%) | $0.71 | $1K | -18.3% | — |
| Aug 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,637218,223 held (−1%) | $0.71 | $1K | -18.3% | — |
| May 19SEC | Faraz AliCEO | Sell | 3,390440,014 held (−1%) | $0.79 | $3K | -26.6% | — |
| May 19SEC | Whittemore TingleyChief Medical Officer | Sell | 3,121215,497 held (−1%) | $0.79 | $2K | -26.6% | — |
| May 19SEC | Tomohiro HigaSvp, Finance | Sell | 1,485118,267 held (−1%) | $0.79 | $1K | -26.6% | — |
| Feb 26SEC | Tcg Opportunity Iii Gp, Llc10% Owner | Sell | 1,862,545 | $0.56 | $1.0M | +3.6% | — |
| Feb 26SEC | Tcg Opportunity Iii Gp, Llc10% Owner | Sell | 1,649,281 | $0.56 | $924K | +3.6% | — |
| Feb 26SEC | Tcg Opportunity Iii Gp, Llc10% Owner | Sell | 349,2121,862,545 held (−16%) | $0.62 | $217K | -6.5% | — |
| Feb 26SEC | Tcg Opportunity Iii Gp, Llc10% Owner | Sell | 309,2281,649,281 held (−16%) | $0.62 | $192K | -6.5% | — |
| Feb 24SEC | Column Group Iii-A, Lp10% Owner | Sell | 277,7692,374,048 held (−10%) | $0.61 | $169K | -4.9% | — |
| Feb 24SEC | Column Group Iii-A, Lp10% Owner | Sell | 245,9652,102,218 held (−10%) | $0.61 | $150K | -4.9% | — |
| Feb 24SEC | Column Group Iii-A, Lp10% Owner | Sell | 162,2912,211,757 held (−7%) | $0.60 | $97K | -3.3% | — |
| Feb 24SEC | Column Group Iii-A, Lp10% Owner | Sell | 143,7091,958,509 held (−7%) | $0.60 | $86K | -3.3% | — |
| Feb 17SEC | Faraz AliCEO | Sell | 5,851452,415 held (−1%) | $0.64 | $4K | -9.4% | — |
| Feb 17SEC | Faraz AliCEO | Sell | 5,032443,404 held (−1%) | $0.64 | $3K | -9.4% | — |
| Feb 17SEC | Faraz AliCEO | Sell | 3,979448,436 held (−1%) | $0.64 | $3K | -9.4% | — |
| Feb 17SEC | Tomohiro HigaSvp, Finance | Sell | 2,022119,752 held (−2%) | $0.64 | $1K | -9.4% | — |
| Feb 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,876218,618 held (−1%) | $0.64 | $1K | -9.4% | — |
| Feb 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,642222,136 held (−1%) | $0.64 | $1K | -9.4% | — |
| Feb 17SEC | Whittemore TingleyChief Medical Officer | Sell | 1,642220,494 held (−1%) | $0.64 | $1K | -9.4% | — |
| Feb 17SEC | Tomohiro HigaSvp, Finance | Sell | 836121,774 held (−1%) | $0.64 | $535 | -9.4% | — |
| Feb 17SEC | Tomohiro HigaSvp, Finance | Sell | 611122,610 held (−0%) | $0.64 | $391 | -9.4% | — |
| Feb 12SEC | Column Group Iii-A, Lp10% Owner | Sell | 2,151,4582,651,817 held (−45%) | $0.68 | $1.5M | -14.7% | — |
| Feb 12SEC | Column Group Iii-A, Lp10% Owner | Sell | 1,905,1152,348,183 held (−45%) | $0.68 | $1.3M | -14.7% | — |
| Feb 12SEC | Column Group Iii-A, Lp10% Owner | Sell | 182,2954,803,275 held (−4%) | $0.82 | $149K | -29.3% | — |
| Feb 12SEC | Column Group Iii-A, Lp10% Owner | Sell | 161,4224,253,298 held (−4%) | $0.82 | $132K | -29.3% | — |
| Nov 17SEC | Faraz AliCEO | Sell | 3,126299,666 held (−1%) | $1.33 | $4K | -56.4% | — |
| Nov 17SEC | Whittemore TingleyChief Medical Officer | Sell | 2,877169,926 held (−2%) | $1.33 | $4K | -56.4% | — |
| Nov 17SEC | Tomohiro HigaSvp, Finance | Sell | 1,36793,971 held (−1%) | $1.33 | $2K | -56.4% | — |
Insiders at Tenaya Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Column Group Iii-A, Lp10% Owner | — | $3.5M | Feb 24, 2026 | — |
| Tcg Opportunity Iii Gp, Llc10% Owner | — | $2.4M | Feb 26, 2026 | — |
| Faraz AliCEO | — | $32K | Aug 17, 2026 | — |
| Whittemore TingleyChief Medical Officer | — | $15K | Aug 17, 2026 | — |
| Tomohiro HigaSvp, Finance | — | $5K | May 19, 2026 | — |
TNYA stock: common questions
Are Tenaya Therapeutics, Inc. insiders buying TNYA stock?
In the past 12 months, 0 insiders reported open-market purchases of TNYA worth $0.
Are Tenaya Therapeutics, Inc. insiders selling TNYA stock?
5 insiders reported sales worth $6.0M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TNYA's 52-week range?
Over the past year TNYA has traded between $0.53 and $2.10. It last closed at $0.58 on Oct 9, 2026.